Insight

Unmet needs, uncommon commitment: The shift toward investment in rare diseases

Unmet needs, uncommon commitment: The shift toward investment in rare diseases

Join biotech leaders, emerging innovators, investors and patient advocacy group reps for a candid, interactive and enlightening discussion about rare disease drug discovery and development.

Digital Health Day sounds a wake up call to challenges in precision medicine

Digital Health Day sounds a wake up call to challenges in precision medicine


Oct 4, 2017

Digital health is here to stay. With or without pharma companies, the digital revolution will overturn business models and reshape healthcare markets just as it...

European biotechs need a strong home public market to support growth

European biotechs need a strong home public market to support growth


Oct 4, 2017

European stock markets are good, but they need to be great to support emerging biotech and medtech companies. How can they be even better? What...

partnering360®: leverage and cultivate your dealmaker network

partnering360 is the network for dealmakers in the life science industry. This global community of more than 40,000 is constantly growing, and the partnering opportunities continually updating.